You Position: Home > Paper
应用抑制性消减杂交技术克隆NS5A-TP2(615)反式激活基因
( views:335, downloads:0 )
- Author:
- No author available
- Journal Title:
- WORLD CHINESE JOURNAL OF DIGESTOLOGY
- Issue:
- 1
- DOI:
- 10.3969/j.issn.1009-3079.2005.01.019
- Key Word:
- No keyword available
Abstract： 目的:应用抑制性消减杂交技术构建人类新基因NS5ATP2(615)反式激活基因差异表达的cDNA消减文库,克隆NS5ATP2反式激活相关基因,了解该基因的可能生物学功能.方法:构建NS5ATP2表达质粒pcDNA3.1(-)NS5ATP2-TP2转染HepG2细胞,以空载体pcDNA3.1(-)转染的HepG2细胞为对照;提取转染后细胞的mRNA,反转录为cDNA.半定量RT-PCR显示实验组NS5ATP2的转录水平明显高于对照组.cDNA经RsaI酶切后,将实验组cDNA分成两组,分别与两种不同的接头衔接,再与对照组cDNA进行两次消减杂交及两次抑制多聚酶链反应(PCR),将产物与pEGM-Teasy载体连接,构建cDNA消减文库,并转染大肠杆菌进行文库扩增,随机挑选克隆PCR扩增后进行测序及同源性分析.结果:成功构建人类新基因NS5ATP2反式激活基因差异表达的cDNA消减文库.文库扩增后得到76个白色克隆,进行菌落PCR分析,均得到200-1000 bp插入片段.挑取含有插入片段的32个克隆进行测序,并通过生物信息学分析获得17种已知功能基因序列,和2个未知功能基因.结论:应用SSH技术成功构建了NS5ATP2反式激活基因差异表达的cDNA消减文库.该文库的建立为阐明NS5ATP2生物学功能提供理论依据.
- [1]成军.慢性病毒性肝炎发病机制的分子生物学研究[J].2002,(2).
- [2]杨倩,成军,刘妍,等.丙型肝炎病毒非结构蛋白NS5A反式激活基因2基因组DNA结构分析及其不同剪切体的克隆化研究[J].2004,(4).
- [3]刘妍,陆荫英,成军,等.丙型肝炎病毒非结构蛋白NS5A反式激活基因的克隆化研究[J].2003,(1).
- [4]Ellington WR,Yamashita D,Suzuki T.Alternative splicing produces transcripts coding for alpha and beta chains of a hetero-dimeric phosphagen kinase.[J].2004,334.
- [5]Street A.,Harris M.,McCormick C.,etc.The hepatitis C virus NS5A protein binds to members of the Src family of tyrosine kinases and regulates kinase activity[J].2004,85(3).
- [6]Astrof S,Crowley D,Sekiguchi K,etc.Direct test of potential roles of EIIIA and EIIIB alternatively spliced segments of fibronectin in physiological and tumor angiogenesis[J].2004,24(19).
- [7]Macdonald A.,Street A.,Harris M.,etc.The hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade[J].2004,279(13).
- [8]D L, Black.Protein diversity from alternative splicing: a challenge for bioinformatics and post-genome biology.[J].2000,103(3).
- [9]Hwang SY,Kim M,Farooq M,etc.Glypican-3 is overexpressed in human hepatocellular carcinoma.[J].2003,94(3).
- [10]I, Wu,M A, Moses.Cloning of a cDNA encoding an isoform of human protein phosphatase inhibitor 2 from vascularized breast tumor.[J].2001,11.
- [11]Eric J, Wagner,Andrea, Baines,Todd, Albrecht,etc.Imaging alternative splicing in living cells.[J].2004,257.
- [12]Michael Gorlick,Robert Riley,Alissa Resch,etc.Assessing the Impact of Alternative Splicing on Domain Interactions in the Human Proteome[J].2004,3(1).
- [13]Akgul C,Moulding DA,Edwards SW.Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications[J].2004,61(17).
- [14]Franco S,Gimenez Barcons M,Puig Basagoiti F,etc.Characterization and evolution of NS5A quasispecies of hepatitis C virus genotype 1b in patients with different stages of liver disease.[J].2003,71(2).
- [15]Robert Steele,Ratna B. Ray,Bhaswati Sarcar,etc.Hepatitis C virus NS5A mediated STAT3 activation requires co-operation of Jak1 kinase[J].2004,322(1).
- [16]A J, Richardson,T, Easton,B K, Puri.Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid.[J].2000,10(3).
- [17]Zolfaghari R,Ross AC.Cloning, gene organization and identification of an alternative splicing process in lecithin:retinol acyltransferase cDNA from human liver.[J].2004,341.
- [18]Weber HC,Walters J,Leyton J,etc.A bombesin receptor subtype-3 peptide increases nuclear oncogene expression in a MEK-1 dependent manner in human lung cancer cells.[J].2001,412(1).
- [19]Stewart D,Matlashewski G,Ghosh A.Regulation of human p53 activity and cell localization by alternative splicing[J].2004,24(18).
- [20]Ishtiaq Qadri,Mieko Iwahashi,Francis Simon.Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3[J].2002,1592(2).
- [21]Goh PY,Tan YJ,Lim SP,etc.The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage[J].2001,290(2).